DelMar Pharmaceuticals, Inc.
Profile
Mailing Address: 999 West Broadway
Suite 720
Vancouver, British Columbia
V5Z 1K5
Head Office Address: 999 West Broadway
Suite 720
Vancouver, British Columbia
V5Z 1K5
Contact Name: Jeffrey Bacha Principal Regulator: British Columbia
Business e-mail address: jbacha@delmarpharma.com Short Form Prospectus Issuer: Yes
Telephone Number: 604 317-7022 Reporting Jurisdictions: British Columbia, Other than Canada
Fax Number: 604 608-5685 Stock Exchange: NASDAQ
Date of Formation: Jun 24 2009 Stock Symbol: DMPI
Jurisdiction Where Formed: Nevada Auditor: Ernst & Young LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 247078 Transfer Agent: Island Stock Transfer Company
Financial Year-End: Jun 30 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents